Premium
The ketogenic diet in two paediatric patients with refractory myoclonic status epilepticus
Author(s) -
Caraballo Roberto Horacio,
Valenzuela Gabriela Reyes,
Armeno Marisa,
Fortini Sebastian,
Mestre Graciela,
Cresta Araceli
Publication year - 2015
Publication title -
epileptic disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.673
H-Index - 53
eISSN - 1950-6945
pISSN - 1294-9361
DOI - 10.1684/epd.2015.0781
Subject(s) - ketogenic diet , status epilepticus , medicine , refractory (planetary science) , epilepsy , tolerability , pediatrics , anesthesia , levetiracetam , myoclonic epilepsy , adverse effect , psychiatry , astrobiology , physics
Aim . We describe two patients with refractory myoclonic status epilepticus treated with the ketogenic diet. Methods . Between May 1, 2014 and January 1, 2015, two patients who met the diagnostic criteria for refractory myoclonic status epilepticus, seen at our department, were placed on the ketogenic diet and followed for a minimum of six months. Results . One patient with myoclonic epilepsy of unknown aetiology had a 75–90% seizure reduction, and the other with progressive encephalopathy associated with myoclonic epilepsy had a 50% seizure reduction. Both patients retained good tolerability for the diet. At the last control, one patient had isolated myoclonias and EEG showed occasional generalized spike‐and‐polyspike waves; the patient is now successfully attending kindergarten. The quality of life of the second patient improved significantly. In both cases, the number of antiepileptic drugs was reduced. Conclusion . The ketogenic diet is an effective and well‐tolerated treatment option for patients with refractory myoclonic status epilepticus and should be considered earlier in the course of treatment.